FOXO TECHNOLOGIES INC. Debt Instrument, Interest Rate, Effective Percentage
FOXO TECHNOLOGIES INC. (FOXO) had Debt Instrument, Interest Rate, Effective Percentage of 20.00% as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateEffectivePercentage · last filed 2026-08-14
- 2026-06-30: Debt Instrument, Interest Rate, Effective Percentage 20.00%.
- 2023-06-30: Debt Instrument, Interest Rate, Effective Percentage 15.00%.
- 2023-03-31: Debt Instrument, Interest Rate, Effective Percentage 15.00%.
- 2022-12-31: Debt Instrument, Interest Rate, Effective Percentage 15.00%.
| Period end | Debt Instrument, Interest Rate, Effective Percentage |
|---|---|
| 2026-06-30 | 20.00% 10-Q · filed 2026-08-14 |
| 2023-06-30 | 15.00% 10-Q · filed 2023-08-10 |
| 2023-03-31 | 15.00% 10-Q · filed 2023-05-11 |
| 2022-12-31 | 15.00% 10-K · filed 2023-03-31 |
| 2022-09-30 | 15.00% 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |